MLN19 – A Key Regulator in Cellular Homeostasis and Disease Pathogenesis

ANTBIO Official Review: MLN19 – A Key Regulator in Cellular Homeostasis and Disease Pathogenesis

Published by ANT BIO PTE. LTD.

Literature Information

This article systematically reviews and re‑analyzes peer‑reviewed publications focused on MLN19, covering its molecular structure, biological functions, related signaling pathways, and implications in disease research. The literature demonstrates that MLN11 acts as a critical regulator in cell proliferation, apoptosis, migration, and invasion, and is closely associated with tumor progression, autoimmune diseases, and neurodegenerative disorders.

Research Background

MLN19 has emerged as a novel molecular target in multiple life science disciplines, with aberrant expression and dysregulation linked to various human diseases. Its functional roles in cell cycle control, survival signaling, and cytoskeletal dynamics have drawn extensive attention. However, high‑quality and validated research reagents are essential for exploring its molecular mechanisms and translational applications.

Research Approach

Based on published studies, we analyzed the molecular structure of MLN19, its biological functions in cell behavior, related signaling pathways (MAPK, PI3K‑Akt, Wnt/β‑catenin), and implications in disease pathogenesis. We further evaluated the application potential of MLN11‑targeted reagents in diagnostic marker development and drug discovery.

Research Findings

1. MLN19 participates in cell cycle regulation, apoptosis, and cell migration/invasion via multiple signaling pathways.
2. Dysregulation of MLN19 contributes to tumor progression, autoimmune disorders, and neurodegenerative diseases.
3. MLN19 holds great potential as a diagnostic biomarker and therapeutic target.
4. High‑quality antibodies, proteins, and kits are essential for exploring MLN19‑related mechanisms and applications.

Product Empowerment by ANT BIO PTE. LTD.

ANT BIO PTE. LTD. provides a complete set of validated reagents to support MLN19‑related research:

• Absin: Universal buffers, tissue lysis reagents, ELISA kits, IHC kits, and general detection kits for sample preparation and signal detection.
• Starter: Highly specific monoclonal and polyclonal antibodies against MLN19, modified MLN19, and related pathway proteins for immunodetection.
• UA: Recombinant MLN19 protein, mutant standards, and functional proteins for mechanism validation and quantitative analysis.

These products enable stable, repeatable, and reliable detection of MLN19 expression, modification, and related signaling activities, accelerating research progress.

Brand Mission

ANT BIO PTE. LTD. is a professional supplier of high‑quality life science reagents, dedicated to providing global researchers with reliable antibodies, recombinant proteins, detection kits, and universal reagents. Through our three specialized sub‑brands—Absin, Starter, and UA—we deliver systematic solutions for protein detection, pathway analysis, disease modeling, and preclinical testing, empowering scientific breakthroughs and translational applications.

Related Product List

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights